July 1, 2016

Orffa gets EC approval for probiotic Calsporin^® for layers

 

The European Commission has approved the use of the probiotic Calsporin^® (Bacillus subtilis C-3102, No. 4b1820 - gut flora stabilizer) for layers.

This is an addition to the existing approval of Calsporin for weaned piglets, broilers, turkeys, minor avian species and other game.

Calsporin contains live spores of Bacillus subtilis C-3102, and with a content of 1.0 x 1010 cfu/gram is highly concentrated. To meet the demands for practical application, Calsporin is extremely heat-stable and has proven viability in the presence of all relevant coccidiostats, therapeutic antibiotics and organic acids.

Calsporin promotes and stabilises an optimal intestinal microflora by shifting the microbial colonisation in favour of mainly Lactobacillus spp.; in turn, the proportion of pathogenic bacteria such as Coliforms, Salmonella and Clostridium spp. will be reduced. By doing this, Calsporin supports the reduction of the ammonia excretion in the faeces.

With a minimum dose of 30 ppm, Calsporin has demonstrated the ability to improve layer feed conversion rate (up to 2%) and increases egg size consistently over the laying period. In older birds (>40 weeks), Calsporin increases laying rate and maintains egg (shell) quality.

Calsporin is manufactured in Japan by Asahi Calpis Wellness Co. Ltd and is being sold and marketed in Europe by Orffa.